Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
14,643 articles
‘Demand destruction has begun’
Pray for Asian naphtha consumers
Echostar Restructuring Paves Way to Revive Possible DirecTV Deal
Echostar Corp. has reached a restructuring agreement with a majority of creditors in its Dish DBS unit, which would potentially pave the way to...
📰
The 96% Blind Spot: Oso and Cyera Research Reveal Unused Permissions Lying in Wait for AI Agents
New study reveals that nearly all enterprise permissions are left untouched by humans, creating a massive risk when agents inherit human access NEW...
Bessent Flags Potential Reserve Release, No Market Intervention
Treasury Secretary Scott Bessent said the US won’t be intervening in financial markets tied to oil, but could potentially release further reserves in...
Super Micro Stock Sees Momentum Score Dip Despite Partner Nvidia's Launch Of New Blackwell AI Chips
Shares of Super Micro Computer Inc. (NASDAQ:SMCI) are facing a stark divergence between its operational milestones and its stock market performance...
Super Micro Stock Sees Momentum Score Dip Despite Partner Nvidia's Launch Of New Blackwell AI Chips
Shares of Super Micro Computer Inc. (NASDAQ:SMCI) are facing a stark divergence between its operational milestones and its stock market performance...
Super Micro Stock Sees Momentum Score Dip Despite Partner Nvidia's Launch Of New Blackwell AI Chips
Shares of Super Micro Computer Inc. (NASDAQ:SMCI) are facing a stark divergence between its operational milestones and its stock market performance...
VinFast Accelerates Its Path to Sustainable Growth Through Smart Manufacturing, AI Integration, and a Diversified EV Portfolio
IRVINE, Calif., March 19, 2026 /PRNewswire/ -- As the global electric vehicle industry enters a more disciplined phase focused on efficiency and...
ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi?
AbbVie stock sinks 5% as J&J's newly approved Icotyde raises competitive concerns for blockbuster Skyrizi in the fast-growing IL-23 market.
ABBV Stock Slides 5%: Is J&J's Icotyde a Threat to Skyrizi?
AbbVie stock sinks 5% as J&J's newly approved Icotyde raises competitive concerns for blockbuster Skyrizi in the fast-growing IL-23 market.
TakeUp's Q1 Research: 2026 is a Year of More "Intentional Travel," Challenging Independent Operators to Remain Sharp on Pricing
"State of Travel Demand 2026" Report Finds that Travel Dollars Aren't Decreasing but are More Scrutinized, Requiring Sensitive and Data-Driven...
Why Are Micron Technology Shares Trading Lower On Thursday?
Micron Technology Inc (NASDAQ:MU) shares are down during pre-market trading on Thursday after the company delivered its second-quarter results on...
Why Are Micron Technology Shares Trading Lower On Thursday?
Micron Technology Inc (NASDAQ:MU) shares are down during pre-market trading on Thursday after the company delivered its second-quarter results on...
📰
Why are gold and silver dropping so much?
In the inflationary environment we seem to be finding ourselves in, and with the instability of war, I’m surprised gold and silver are dropping so...
📰
Bond Traders No Longer Price In Any Chance of Fed Cut in 2026
Treasuries sank and traders no longer priced in any chance of an interest-rate cut the US this year after the Bank of England said it would be ready...
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Organizational restructuring and cost reduction plan following results of the Phase 3 CYPRESS study of ampreloxetine are underway; expected to...
Accenture Stock Hits 52-Week Low - Here's Why
Accenture plc (NYSE:ACN) shares fell Thursday after the company's fiscal second-quarter 2026 results, as a cautious outlook overshadowed an...
Accenture Stock Hits 52-Week Low - Here's Why
Accenture plc (NYSE:ACN) shares fell Thursday after the company's fiscal second-quarter 2026 results, as a cautious outlook overshadowed an...
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for...
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for...
